Merge Healthcare (MRGE) Tops Q2 EPS by 3c

Merge Healthcare (NASDAQ: MRGE) reported Q2 EPS of $0.09, $0.03 better than the analyst estimate of $0.06. Revenue for the quarter came in at $65.6 million versus the consensus estimate of $63.89 million.

For earnings history and earnings-related data on Merge Healthcare (MRGE) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Benchmark Reiterates Hold Rating on Codexis, Inc. (CDXS) Amid Transition to New Products/Services
• Twin Disc (TWIN) Tops Q4 EPS by 16c